http://optimark.legalview.com/msn/ 2012-02-23 http://optimark.legalview.com/msn/mri-contrast-agents-to-carry-kidney-disease-warning/1234446/ 2012-02-23 http://optimark.legalview.com/msn/fda-warns-not-to-use-some-mri-contrast-agents-with-kidney-patients/1234445/ 2012-02-23 http://optimark.legalview.com/msn/fda-strengthens-warnings-on-certain-drugs-used-in-mri-scans/1234444/ 2012-02-23 http://optimark.legalview.com/msn/fda-adds-warning-to-some-diagnostic-drugs/1234443/ 2012-02-23 http://optimark.legalview.com/msn/fda-warns-mri-imaging-drugs-can-be-fatal/1234442/ 2012-02-23 http://optimark.legalview.com/msn/fda-requires-stronger-warnings-on-some-mri-contrast-agents/1234441/ 2012-02-23 http://optimark.legalview.com/msn/fda-urges-new-warnings-on-imaging-agents/1234440/ 2012-02-23 http://optimark.legalview.com/msn/mri-gadolinium-health-risks/1234439/ 2012-02-23 http://optimark.legalview.com/msn/covidien-supports-fdas-patient-safety-efforts-for-gadolinium-based-con/1234438/ 2012-02-23 http://optimark.legalview.com/msn/unfair-at-any-speed/1196287/ 2012-02-23 http://optimark.legalview.com/msn/covidien-submits-label-change-for-optimark-contrast-agent/1131492/ 2012-02-23 http://optimark.legalview.com/msn/covidien-adds-kidney-risk-to-optimark-label/1131491/ 2012-02-23 http://optimark.legalview.com/msn/the-nyse-the-anti-emulex/1108725/ 2012-02-23